The artificial intelligence rally led by the so-called Magnificent 7 over the past two years has been remarkable if you owned ...

Fintel reports that on January 30, 2025, Goldman Sachs upgraded their outlook for RH (NYSE:RH) from Sell to Neutral. As of January 29, 2025, the average one-year price target for RH is $467.74/share.

You should consider the Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC), a passively managed exchange traded fund launched on 06/28/2017. The fund is sponsored by Goldman Sachs Funds.

Between you-only-live-once retail traders, big corporates buying back their stock and retirement allocation demand, the bears ...

Deep-pocketed investors have adopted a bearish approach towards Goldman Sachs Gr (NYSE:GS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

Fintel reports that on January 27, 2025, Goldman Sachs upgraded their outlook for Twilio (WBAG:TWLO) from Neutral to Buy. There are 1,067 funds or institutions reporting positions in Twilio.

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (WBAG:MRNA) from Buy to Neutral. There are 1,449 funds or institutions reporting positions in Moderna.

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (XTRA:0QF) from Buy to Neutral. As of January 28, 2025, the average one-year price target for Moderna is ...

Fintel reports that on January 29, 2025, Goldman Sachs downgraded their outlook for Moderna (BIT:1MRNA) from Buy to Neutral. As of January 28, 2025, the average one-year price target for Moderna ...

Tesla (NASDAQ:TSLA) will be under the Street’s microscope today with the EV giant slated to release 4Q24 results after the ...

Fintel reports that on January 30, 2025, Goldman Sachs upgraded their outlook for RH (LSE:0KTF) from Sell to Neutral. There are 794 funds or institutions reporting positions in RH. This is an ...